JXR Completes HKD 4.11 Million Buyback, Treasury Shares Climb to 44.30 Million

Bulletin Express10-14

On 14 October 2026, Jinxin Fertility Group Limited (abbreviation: JXR) repurchased 1.80 million ordinary shares on the Stock Exchange of Hong Kong, paying a total of HKD 4.11 million. The shares were acquired at prices ranging from HKD 2.265 to HKD 2.31, with a volume-weighted average cost of HKD 2.277 per share.

Following the transaction, JXR’s issued share capital (excluding treasury shares) fell by 0.07% to 2.66 billion shares, while the treasury-share balance rose from 42.49 million to 44.30 million. The company’s total issued shares remain unchanged at 2.71 billion.

Since the current buyback mandate was approved on 25 June 2026, JXR has repurchased 56.84 million shares, representing 2.17% of the company’s issued share count on the mandate date. The authorised limit under the mandate stands at 262.51 million shares, indicating 78% of the allowance is still available.

In addition to the latest on-market purchase, 92.47 million shares previously bought under the programme are awaiting formal cancellation.

Pursuant to Hong Kong Listing Rules, a moratorium restricts JXR from issuing new shares or transferring treasury shares until 13 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment